Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-EN | Version v5-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2025-10-01 | 2025-10-01 |
| Drug Identification Number | 244 | 244 |
| Brand name | Francesca Oneil | Francesca Oneil |
| Common or Proper name | 434 | Anika Fuller |
| Company Name | ERFA CANADA 2012 INC | ERFA CANADA 2012 INC |
| Ingredients | Nam deserunt accusan | Nam deserunt accusan |
| Strength(s) | Et veniam ab irure | Et veniam ab irure |
| Dosage form(s) | Voluptatum aliquip u | Voluptatum aliquip u |
| Route of administration | Et exercitationem es | Et exercitationem es |
| Packaging size | rere | 957 |
| Additional packaging sizes | ||
| ATC code | 305 | 305 |
| ATC description | Voluptas lorem neque | Voluptas lorem neque |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2020-04-01 | 2020-04-01 |
| Actual start date | 2030-06-01 | 2020-06-01 |
| Estimated end date | 2020-11-01 | 2020-11-01 |
| Actual end date | 2025-01-01 | 2020-01-01 |
| Shortage status | Avoided shortage | Avoided shortage |
| Tier 3 Status | No | No |
| Company comments | Vel ipsa veniam ne | Vel ipsa veniam ne |
| Health Canada comments | Ex commodo consequat | Ex commodo consequat |